Tag Archives: QURE

January 16, 2020   No comments

Thursday’s Midday Movers: uniQure (QURE), Alcoa (AA), Goodrich Petroleum (GDP), Second Sight Medical Products (EYES)

So far Thursday, January 16, NASDAQ is up 0.8% and the S&P is up 0.11%. Here are this morning’s most active stocks: uniQure (QURE – Research Report), Alcoa (AA – Research Report), Goodrich Petroleum (GDP – Research Report) and Second

Read More
January 13, 2020   No comments

Monday’s Highlights at Noon: SunPower (SPWR), ACADIA Pharmaceuticals (ACAD), Blueprint Medicines (BPMC), uniQure (QURE), Ballard Power Systems (BLDP)

So far Monday, January 13, NASDAQ is up 2.43% and the S&P is up 1.12%. Here are this morning’s most active stocks: SunPower (SPWR – Research Report), ACADIA Pharmaceuticals (ACAD – Research Report), Blueprint Medicines (BPMC – Research Report), uniQure

Read More
December 15, 2019   No comments

Sunday’s Midday Stock Update: Whiting Petroleum (WLL), uniQure (QURE), Cytokinetics (CYTK), TG Therapeutics (TGTX), Dynavax (DVAX)

So far Sunday, December 15, NASDAQ is up 0.32% and the S&P is up 0.45%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Whiting Petroleum (WLL – Research Report), uniQure (QURE – Research

Read More
December 14, 2019   No comments

Saturday’s Midday Stock Update: Whiting Petroleum (WLL), uniQure (QURE), Cytokinetics (CYTK), TG Therapeutics (TGTX), Dynavax (DVAX)

So far Saturday, December 14, NASDAQ is up 0.32% and the S&P is up 0.45%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Whiting Petroleum (WLL – Research Report), uniQure (QURE – Research

Read More
December 9, 2019   No comments

H.C. Wainwright Sticks to Its Buy Rating for uniQure (QURE)

H.C. Wainwright analyst Debjit Chattopadhyay maintained a Buy rating on uniQure (QURE – Research Report) today and set a price target of $73.00. The company’s shares closed last Monday at $62.73. According to TipRanks.com, Chattopadhyay is a 4-star analyst with

Read More
December 9, 2019   No comments

Chardan Capital Keeps Their Buy Rating on uniQure (QURE)

Chardan Capital analyst Gbola Amusa reiterated a Buy rating on uniQure (QURE – Research Report) today and set a price target of $125.00. The company’s shares closed last Monday at $66.70. According to TipRanks.com, Amusa is a top 100 analyst

Read More
« Older posts